Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

406
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
406
Relative Risk01:12

Relative Risk

262
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
262
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

234
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
234
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

440
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
440
Cancer Prevention02:59

Cancer Prevention

6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of apolipoprotein B and excess apolipoprotein B with cardiovascular risk in type 2 diabetes: a prospective cohort study of the UK Biobank.

Lipids in health and disease·2026
Same author

Macrophage-Specific E3 Ubiquitin Ligase TRIM31 Reduces Atherosclerotic Plaque Formation by Targeting LOX-1.

Circulation·2025
Same author

Development and performance of female breast cancer incidence risk prediction models: a systematic review and meta-analysis.

Annals of medicine·2025
Same author

The efficacy of psychosocial interventions on anxiety and depression in cancer caregivers: a network meta-analysis.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2025
Same author

Regulation of TAK-TAB Complex Activation through Ubiquitylation.

Frontiers in bioscience (Landmark edition)·2024
Same author

An advanced machine learning method for simultaneous breast cancer risk prediction and risk ranking in Chinese population: A prospective cohort and modeling study.

Chinese medical journal·2024

Related Experiment Video

Updated: Aug 4, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

312

An Improved Training Algorithm Based on Ensemble Penalized Cox Regression for Predicting Absolute Cancer Risk.

Liyuan Liu1,2, Fu Yang3, Yeye Fan2

  • 1Department of Breast Surgery, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan City, Shandong Province, China.

China CDC Weekly
|April 3, 2023
PubMed
Summary

The ensemble penalized Cox regression (EPCR) procedure improves cancer risk prediction models by addressing imbalanced data. This method enhances variable screening accuracy and outperforms traditional models, particularly for breast cancer risk assessment.

Keywords:
Absolute risk predictionCox RegressionEnsemble LearningImbalanced data

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.1K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K

Related Experiment Videos

Last Updated: Aug 4, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

312
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.1K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K

Area of Science:

  • Biostatistics
  • Epidemiology
  • Machine Learning in Healthcare

Background:

  • Cancer incidence data often exhibit biases, leading to imbalanced databases in prospective cohort studies.
  • Imbalanced datasets negatively impact the performance of traditional algorithms used for training cancer risk prediction models.

Purpose of the Study:

  • To enhance the predictive performance of cancer risk assessment tools.
  • To evaluate the effectiveness of a novel ensemble penalized Cox regression (EPCR) framework in handling imbalanced data.

Main Methods:

  • Introduced a Bagging ensemble framework to an absolute risk model based on ensemble penalized Cox regression (EPCR).
  • Conducted six simulation studies with 100 replicates, varying censoring rates to compare EPCR with traditional regression models.
  • Assessed model performance using metrics like false discovery rate, false omission rate, true positive rate, true negative rate, and AUC.

Main Results:

  • The EPCR procedure demonstrated improved variable screening by reducing the false discovery rate (FDR) at a similar true positive rate (TPR).
  • Applied to the Breast Cancer Cohort Study in Chinese Women, EPCR yielded significantly higher AUC values for 3- and 5-year breast cancer risk prediction compared to the Gail model.
  • Achieved AUCs of 0.691 (3-year) and 0.642 (5-year), outperforming the Gail model by 0.189 and 0.117, respectively.

Conclusions:

  • The EPCR procedure effectively overcomes challenges associated with imbalanced data in cancer risk prediction.
  • EPCR enhances the accuracy and performance of cancer risk assessment tools, offering a more reliable approach for clinical applications.